NSEGeneral Updates4d ago · 5 Nov 2026, 01:29 pm
General Updates
Mankind Pharma Limited · MANKIND
✦ AI SummaryESG
Mankind Pharma Limited has informed the Exchange about General Updates, specifically the assignment of an Environmental, Social, and Governance (ESG) Rating of '64.8' by SES ESG Research Private Limited.
Analysis Scores
Earnings Impact1/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
MANKIND1_05112026132852_20261104_ESG_Ratings_SES_SD.pdf
View document text
November 5, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of Environmental, Social and Governance (ESG) Rating
Ref.: Regulation 30 & 51 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“Listing
Regulations”)
With reference to the captioned subject, we wish to inform you SES ESG Research Private
Limited (“SES”), a SEBI registered ESG Rating Provider, has assigned the Environmental,
Social, and Governance (ESG) Rating of ‘64.8’ to the Company.
The Company has not engaged SES for the said rating, same has been independently assigned
by SES for FY26, based on publicly available information.
The above disclosure is also being made available on the Company’s website at
www.mankindpharma.com.
This is for your information and records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer